Hoang et al. 2019 (PRJNA566449)
General Details
Title | Induction of an alternative 5' leader enhances translation of Inpp5e and resistance to oncolytic virus infection |
---|---|
Organism | |
Number of Samples | 8 |
Release Date | 2019/09/19 00:00 |
Sequencing Types | |
Protocol Details |
Study Links
GWIPS-viz | Trips-Viz |
---|---|
Repository Details
SRA | SRP222582 |
---|---|
ENA | SRP222582 |
GEO | GSE137757 |
BioProject | PRJNA566449 |
Publication
Title | |
---|---|
Authors | Hoang HD, Graber TE, Jia JJ, Vaidya N, Gilchrist VH, Xiang X, Li W, Cowan KN, Gkogkas CG, Jaramillo M, Jafarnejad SM, Alain T |
Journal | Cell reports |
Publication Date | 2019 Dec 17 |
Abstract | Residual cell-intrinsic innate immunity in cancer cells hampers infection with oncolytic viruses. Translational control of mRNA is an important feature of innate immunity, yet the identity of translationally regulated mRNAs functioning in host defense remains ill-defined. We report the translatomes of resistant murine '4T1' breast cancer cells infected with three of the most clinically advanced oncolytic viruses: herpes simplex virus 1, reovirus, and vaccinia virus. Common among all three infections are translationally de-repressed mRNAs, including Inpp5e, encoding an inositol 5-phosphatase that modifies lipid second messenger signaling. We find that viral infection induces the expression of an Inpp5e mRNA variant that lacks repressive upstream open reading frames (uORFs) within its 5' leader and is efficiently translated. Furthermore, we show that INPP5E contributes to antiviral immunity by altering virus attachment. These findings uncover a role for translational control through alternative 5' leader expression and assign an antiviral function to the ciliopathy gene Inpp5e. Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved. |
PMC | |
PMID | 31851930 |
DOI |
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRR10149785 | PRJNA566449 | Mus musculus | 4T1 | Ribo-Seq | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR10149787 | PRJNA566449 | Mus musculus | 4T1 | Ribo-Seq | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR10149789 | PRJNA566449 | Mus musculus | 4T1 | Ribo-Seq | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR10149791 | PRJNA566449 | Mus musculus | 4T1 | Ribo-Seq | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR10149793 | PRJNA566449 | Mus musculus | 4T1 | Ribo-Seq | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR10149795 | PRJNA566449 | Mus musculus | 4T1 | Ribo-Seq | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR10149797 | PRJNA566449 | Mus musculus | 4T1 | Ribo-Seq | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR10149799 | PRJNA566449 | Mus musculus | 4T1 | Ribo-Seq | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) |
ⓘ For more Information on the columns shown here see: About